566 related articles for article (PubMed ID: 24090605)
1. Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia.
Del Principe MI; Buccisano F; Maurillo L; Venditti D; Cefalo M; Sarlo C; Di Caprio L; Di Veroli A; Nasso D; Ceresoli E; Postorino M; Di Piazza F; Colandrea G; Conti F; Del Poeta G; Amadori S; Venditti A
Thromb Res; 2013 Nov; 132(5):511-4. PubMed ID: 24090605
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience.
Grisariu S; Spectre G; Kalish Y; Gatt ME
Eur J Haematol; 2013 May; 90(5):397-403. PubMed ID: 23414485
[TBL] [Abstract][Full Text] [Related]
4. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm.
Goltz JP; Schmid JS; Ritter CO; Knödler P; Petritsch B; Kirchner J; Hahn D; Kickuth R
J Vasc Access; 2012; 13(1):79-85. PubMed ID: 21786241
[TBL] [Abstract][Full Text] [Related]
5. Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters.
Refaei M; Fernandes B; Brandwein J; Goodyear MD; Pokhrel A; Wu C
Ann Hematol; 2016 Dec; 95(12):2057-2064. PubMed ID: 27542955
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
Verso M; Agnelli G
J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
[TBL] [Abstract][Full Text] [Related]
7. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer.
Debourdeau P; Farge D; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Büller HR; Bounameaux H
J Thromb Haemost; 2013 Jan; 11(1):71-80. PubMed ID: 23217208
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters.
Marnejon T; Angelo D; Abu Abdou A; Gemmel D
J Vasc Access; 2012; 13(2):231-8. PubMed ID: 22266584
[TBL] [Abstract][Full Text] [Related]
9. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
[TBL] [Abstract][Full Text] [Related]
10. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
11. The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients.
Lv S; Liu Y; Wei G; Shi X; Chen S; Zhang X
Medicine (Baltimore); 2019 Nov; 98(47):e17894. PubMed ID: 31764785
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
Brandão LR; Shah N; Shah PS
Cochrane Database Syst Rev; 2014 Mar; (3):CD005982. PubMed ID: 24615288
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin for deep vein thrombosis in glioma patients.
Schmidt F; Faul C; Dichgans J; Weller M
J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
[TBL] [Abstract][Full Text] [Related]
15. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen.
Htun KT; Ma MJY; Lee AYY
J Thromb Thrombolysis; 2018 Oct; 46(3):386-392. PubMed ID: 30014300
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis.
Perek S; Khatib A; Izhaki N; Khalaila AS; Brenner B; Horowitz NA
Eur J Intern Med; 2022 Jul; 101():68-75. PubMed ID: 35527180
[TBL] [Abstract][Full Text] [Related]
18. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities.
Greene MT; Flanders SA; Woller SC; Bernstein SJ; Chopra V
Am J Med; 2015 Sep; 128(9):986-93.e1. PubMed ID: 25940453
[TBL] [Abstract][Full Text] [Related]
19. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
Zeidler K; Arn K; Senn O; Schanz U; Stussi G
Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
[TBL] [Abstract][Full Text] [Related]
20. Central venous catheter-related thrombosis in intensive care patients - incidence and risk factors: A prospective observational study.
Hrdy O; Strazevska E; Suk P; Vach R; Karlik R; Jarkovsky J; Sas I; Gal R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Dec; 161(4):369-373. PubMed ID: 28839334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
